Bettina Ryll

Bettina Ryll, MD/PhD founded the Melanoma Patient Network Europe after loosing her husband to Melanoma and developed a special interest in patient-centric clinical research and drug development. Bettina’s current areas of focus are Adaptive Licensing/ MAPPS , innovative sustainable healthcare models and patient-centered risk/ benefit assessment tools. Bettina lectures and advises on patient-centric drug development; she is member of ASCO and ISPOR and currently holds the Chair of the ESMO Patient Advocacy Working Group.